pubmed-article:7594023 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:7594023 | lifeskim:mentions | umls-concept:C0205042 | lld:lifeskim |
pubmed-article:7594023 | lifeskim:mentions | umls-concept:C0004153 | lld:lifeskim |
pubmed-article:7594023 | lifeskim:mentions | umls-concept:C0085542 | lld:lifeskim |
pubmed-article:7594023 | lifeskim:mentions | umls-concept:C1261322 | lld:lifeskim |
pubmed-article:7594023 | lifeskim:mentions | umls-concept:C0449258 | lld:lifeskim |
pubmed-article:7594023 | lifeskim:mentions | umls-concept:C0301630 | lld:lifeskim |
pubmed-article:7594023 | lifeskim:mentions | umls-concept:C0449295 | lld:lifeskim |
pubmed-article:7594023 | lifeskim:mentions | umls-concept:C2827664 | lld:lifeskim |
pubmed-article:7594023 | lifeskim:mentions | umls-concept:C0048838 | lld:lifeskim |
pubmed-article:7594023 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:7594023 | pubmed:dateCreated | 1995-12-5 | lld:pubmed |
pubmed-article:7594023 | pubmed:abstractText | This study was designed to evaluate the effect of pravastatin on progression of coronary atherosclerosis and ischemic events in patients with coronary artery disease and mild to moderate hyperlipidemia. | lld:pubmed |
pubmed-article:7594023 | pubmed:language | eng | lld:pubmed |
pubmed-article:7594023 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7594023 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:7594023 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7594023 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7594023 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7594023 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:7594023 | pubmed:month | Nov | lld:pubmed |
pubmed-article:7594023 | pubmed:issn | 0735-1097 | lld:pubmed |
pubmed-article:7594023 | pubmed:author | pubmed-author:PittBB | lld:pubmed |
pubmed-article:7594023 | pubmed:author | pubmed-author:ParkJ SJS | lld:pubmed |
pubmed-article:7594023 | pubmed:author | pubmed-author:EllisS GSG | lld:pubmed |
pubmed-article:7594023 | pubmed:author | pubmed-author:ManciniG BGB | lld:pubmed |
pubmed-article:7594023 | pubmed:author | pubmed-author:RosmanH SHS | lld:pubmed |
pubmed-article:7594023 | pubmed:author | pubmed-author:McGovernM EME | lld:pubmed |
pubmed-article:7594023 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:7594023 | pubmed:day | 1 | lld:pubmed |
pubmed-article:7594023 | pubmed:volume | 26 | lld:pubmed |
pubmed-article:7594023 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:7594023 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:7594023 | pubmed:pagination | 1133-9 | lld:pubmed |
pubmed-article:7594023 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
pubmed-article:7594023 | pubmed:meshHeading | pubmed-meshheading:7594023-... | lld:pubmed |
pubmed-article:7594023 | pubmed:meshHeading | pubmed-meshheading:7594023-... | lld:pubmed |
pubmed-article:7594023 | pubmed:meshHeading | pubmed-meshheading:7594023-... | lld:pubmed |
pubmed-article:7594023 | pubmed:meshHeading | pubmed-meshheading:7594023-... | lld:pubmed |
pubmed-article:7594023 | pubmed:meshHeading | pubmed-meshheading:7594023-... | lld:pubmed |
pubmed-article:7594023 | pubmed:meshHeading | pubmed-meshheading:7594023-... | lld:pubmed |
pubmed-article:7594023 | pubmed:meshHeading | pubmed-meshheading:7594023-... | lld:pubmed |
pubmed-article:7594023 | pubmed:meshHeading | pubmed-meshheading:7594023-... | lld:pubmed |
pubmed-article:7594023 | pubmed:meshHeading | pubmed-meshheading:7594023-... | lld:pubmed |
pubmed-article:7594023 | pubmed:meshHeading | pubmed-meshheading:7594023-... | lld:pubmed |
pubmed-article:7594023 | pubmed:meshHeading | pubmed-meshheading:7594023-... | lld:pubmed |
pubmed-article:7594023 | pubmed:meshHeading | pubmed-meshheading:7594023-... | lld:pubmed |
pubmed-article:7594023 | pubmed:year | 1995 | lld:pubmed |
pubmed-article:7594023 | pubmed:articleTitle | Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation. | lld:pubmed |
pubmed-article:7594023 | pubmed:affiliation | University of Michigan Hospital, Ann Arbor 48109-0366, USA. | lld:pubmed |
pubmed-article:7594023 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:7594023 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:7594023 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:7594023 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:7594023 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7594023 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7594023 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7594023 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7594023 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7594023 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7594023 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7594023 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7594023 | lld:pubmed |